All filters
E-Posters
Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement - Robert Ehret
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
A Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in Ukraine - Zahedul Islam
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Sensitivity of ultra-deep sequencing for dual HIV infection detection - Darya Saleeva
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
A Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical Samples - Andreas Chrysostomou
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Use of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico. - Luis Del Carpio-Orantes
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
PK-virological algorithm to target risk of resistance among key populations in Togo - Valentine Ferré
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Longitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020 - Marcel Schuetze
Presented at:
European Meeting on HIV & Hepatitis 2021
Meeting
APACC 2021
Abstracts
Amnestic Neurocognitive Impairment in Older Adults Living with HIV with Immune Recovery Following Delayed Antiretroviral Treatment in Northern Thailand
L. Aurpibul
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Association between the levels of serum free testosterone levels and lifestyle-related diseases in people living with HIV
Y. Yoshino
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Immune profile of COVID-19 patients treated with corticosteroids vs anti-interleukin 6 {tocilizumab) for cytokine release syndrome.
R. Rajasuriar
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Mental health and nutritional services in a community-based clinic during the COVID-19 pandemic {The HERCULES Project)
C. Chang
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
A cross-sectional online survey on HIV/STI-related knowledge, tendencies towards stigma, and willingness to HIV/STI screening among allied health students in Iloilo, Philippines
R. Olete,
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Performance of HCV antigen assay in the diagnosis of acute HCV infection among at-risk people living with HIV
H. Shun
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Impact of COVID-19 on HIV testing and care at a university hospital in Taiwan
P. Wu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Preference and ability to perform blood-based versus oral fluidbased HIV self-testing in adolescents and young adults aged 18- 24 years at risk of HIV acquisition in Thailand: a cross-sectional study
P. Trabwongwitaya
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Sarcopenia in PLWH in Asia: Which definition correlates with health outcomes?
W. Luk
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
High rates of depressive symptoms, suicidal ideation, and substance use among adults living with HIV in the Asia-Pacific region.
J. Ross
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Factors associated with mental health screening preferences among people living with HIV receiving care at a tertiary care hospital in Malaysia
M. Chong,
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Durable efficacy of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral treatment-naive adults with HIV-1 infection: 3-year results from the GEMINI studies in participants from Asian centers
C. Huang
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/T AF) among people living with HIV in a real-world setting
C. Chen
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Cost-Effectiveness of DTG/3TC for human immunodeficiency virus (HIV-1) infection treatment in Taiwan
Ou H.
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in treatment experienced patients -Asian Real-world Experience
H. Tsai
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Real-world effectiveness, safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF} in routine clinical practice in people living with HIV (PLWH}, China
T. Yu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021